to investigate this possibility , variable-interval self-stimulation performance was used to monitor 'intrinsic ' benzodiazepine-like and anti- benzodiazepine activity by the 'neutral ' benzodiazepine-receptor antagonist , ro 15-1788 ( flumazenil ) ( 10 or 30 mg/kg intraperitoneally ) .
C0005064
benzodiazepine
C0016293
flumazenil